

Capecitabine (Xeloda) is an oral chemotherapy drug used to treat breast, colon, and other cancers. Learn about uses, dosage, costs, and more.
Capecitabine — sold under the brand name Xeloda — is one of the most widely prescribed oral chemotherapy medications in the world. Unlike traditional IV chemotherapy that requires you to sit in an infusion center, Capecitabine is a tablet you take at home. It's a prodrug of 5-Fluorouracil (5-FU), meaning your body converts it into the active cancer-fighting compound after you swallow it.
If you or someone you love has been prescribed Capecitabine, this guide covers everything you need to know: what it treats, how to take it, who shouldn't take it, and what it costs in 2026.
Here are the key facts:
Capecitabine works by converting to 5-FU primarily inside tumor cells, where the enzyme thymidine phosphorylase is found in higher concentrations. This targeted activation means it delivers chemotherapy preferentially to cancer tissue. For a deeper explanation, see our article on how Capecitabine works.
Capecitabine is FDA-approved to treat several types of cancer:
Capecitabine is used for metastatic breast cancer, either as a single agent (for patients resistant to Paclitaxel and anthracycline-containing regimens) or in combination with Docetaxel. It's an important option when other treatments have stopped working.
After surgery to remove stage III (Dukes C) colon cancer, Capecitabine is given as adjuvant therapy to reduce the risk of the cancer coming back. It's often preferred over IV 5-FU because patients can take it at home.
Capecitabine is approved as first-line treatment for metastatic colorectal cancer when fluoropyrimidine therapy alone is preferred.
Used in combination with platinum-based chemotherapy regimens for gastric cancer.
Combined with Gemcitabine for the treatment of pancreatic cancer.
Added as an approved indication for esophageal cancer treatment.
Oncologists may also prescribe Capecitabine off-label for hepatobiliary cancers, ovarian cancer, neuroendocrine tumors, head and neck cancers, and renal cell carcinoma.
Capecitabine is taken by mouth (orally) as a tablet. Here's what you need to know about the dosing:
Because the dose is calculated by body surface area, you'll likely take a combination of 150 mg and 500 mg tablets to get the right amount. Your pharmacist can help you understand exactly which tablets to take and when.
Capecitabine is not safe for everyone. You should not take it if you have:
Special caution is also needed for:
The cost of Capecitabine varies significantly depending on whether you use brand or generic, your pharmacy, and your insurance:
Most commercial insurance plans and Medicare Part D cover Capecitabine. It's generally classified as a specialty oral oncology medication. Some key points:
If you're struggling with costs, several programs can help:
For a complete breakdown, read our guide to saving money on Capecitabine.
Capecitabine is a well-established oral chemotherapy option that gives cancer patients the convenience of at-home treatment instead of regular IV infusions. It's effective across multiple cancer types and has been available in generic form for years, making it more accessible than many newer oncology drugs.
That said, it's still a serious medication that requires careful monitoring, DPD testing before starting, and regular follow-ups with your oncologist. If you've been prescribed Capecitabine, don't hesitate to ask your care team about side effects to watch for, drug interactions, and how to find the right doctor.
Need help finding Capecitabine at a pharmacy near you? Medfinder can help you locate it in stock quickly.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.